Severe hepatitis B virus reactivation related to ibrutinib monotherapy

Ann Hematol. 2017 Apr;96(4):689-690. doi: 10.1007/s00277-016-2917-2. Epub 2017 Jan 5.

Authors

Yair Herishanu¹, Helena Katchman², Aaron Polliack³

Affiliations

¹ Department of Hematology, Tel-Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. yairh@tasmc.health.gov.il.
² Department of Gastroenterology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
³ Hebrew University Medical School, Jerusalem, Israel.

PMID: 28058492
DOI: 10.1007/s00277-016-2917-2

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenine / analogs & derivatives
Aged
Hepatitis B / chemically induced*
Hepatitis B / complications
Hepatitis B / pathology
Hepatitis B / virology*
Hepatitis B virus / drug effects*
Hepatitis B virus / physiology
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / complications
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
Leukemia, Lymphocytic, Chronic, B-Cell / virology
Male
Piperidines
Pyrazoles / adverse effects*
Pyrimidines / adverse effects*
Severity of Illness Index
Virus Activation / drug effects*

Substances

Piperidines
Pyrazoles
Pyrimidines
ibrutinib
Adenine